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English Summary  
 
The main attempt of this thesis is to link the medicalization theory to the discourse of 
medical knowledge production under neoliberal conditions. Neoliberalism increased the political 
and economic power of the private industry in research and has therefore changed the way 
knowledge is produced dramatically. Analyzing these changes in knowledge production as a 
global phenomenon in general, the thesis looks at medical knowledge production in particular. 
The most important actor in this context is the pharmaceutical industry, which plays an 
important role in both the medicalization theory in the production of medical knowledge. The 
pharmaceutical industry is one of the fastest growing branches of the global economy as the 
neoliberal system provided it with favorable framework conditions to bring new drugs to the 
market while at the same time produce knowledge to boost their sales.  Of particular interest is 
the development of new drugs (especially clinical trials) as well as the marketing of them, 
demonstrating how the market is actually intertwined with the medicalization and medical 
knowledge production.  
    
German Summary 
 
Das Ziel der vorliegenden Arbeit ist es, die Medikalisierungstheorie in Verbindung zu 
stellen mit medizinischer Wissensproduktion unter neoliberalen Bedingungen. Neoliberalismus 
hat die politische und wirtschaftliche Macht der Privatwirtschaft in Wissenschaft und Forschung 
verstärkt und dadurch auch die Wissensproduktion verändert. Diese Veränderungen werden in 
der vorliegenden Arbeit global beleuchtet und mit medizinischer Wissensproduktion 
verknüpft. Der wichtigste Akteur in diesem Zusammenhang ist die pharmazeutische Industrie. 
Sie ist eine der am schnellsten wachsenden Wirtschaftszweige in der globalen Wirtschaft. 
Weiters profitiert sie stark vom Neoliberalismus, der ihr für das Marketing von Medikamenten 
viele Freiheiten gebracht hat. Die Rolle des globalen Marktes hinsichtlich der 
Medikamentenentwicklung ist daher ein weiterer Fokus. 
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Preface 
 
 
When it came to making a decision for the topic of my Master Thesis, I found myself 
struggling with many different ideas as I have more than one academic background. Holding a 
bachelor’s degree in Communication Sciences and having studied many different disciplines in 
the course of my Master’s Program Global Studies, such as International Development, Global 
History, Anthropology, Sociology and Political Science, it became very difficult for me to narrow 
my theoretical framework down to something that ideally combines all of them. I needed to find 
a topic that gave me the freedom to use different perspectives and approaches. Therefore, my 
approach is now a very interdisciplinary one. I am looking at health and society mostly from a 
sociological perspective, but also bringing in the role of the media from a communication 
sciences perspective. Most importantly, I am approaching my topic from a global perspective, 
breaking down global developments and analyzing how they influence society at a certain point.  
Before I started the Global Studies Master’s program, I was working for the 
pharmaceutical industry doing public relations, which stimulated my interest in health and society 
in the first place. Working for the health care industry made me curious to find out more about 
the interplay of all stakeholders in the development of a new drug: On the one hand, the 
pharmaceutical industry, a huge, fast growing global industry which has become a highly 
criticized global, economic actor and receives a lot of attention from the media. On the other 
hand, the patients, who are no longer simply the receivers of drugs but have become important, 
active actors in the whole process around the development of new drugs.  
I realized that the development and launch of a new drug is much more complicated and 
complex than I have ever thought and started to highly question everything that I was part of by 
working for the pharmaceutical industry. Without evaluating anything as positive or negative, I 
wanted to research more about the fascinating interaction of powers that are involved in health 
care industry. Coming from a Global Studies perspective, I decided to analyze the pharmaceutical 
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industry as an economic and political actor within a capitalistic, global economic system and 
neoliberalism in particular. 
When I did my university exchange to Dalhousie University in Halifax, Canada, I chose 
several classes with a focus on health and society. This gave me the chance to compare my 
practical experience with the pharmaceutical industry to academic theory.   
My main perspective now is of course a social science one. Obviously, as I am not a 
medical scientist, it is not the goal of this thesis to analyze the specific content of medical research 
or clinical trials, but rather to look at how scientific, medical facts are produced, from a social 
science perspective. This means that I am not looking at the actual research per se, but rather at 
who is behind the research, whom does it benefit, and what are the specific interests of all the 
various stakeholders? Last but not least, how do drugs affect society? In fact, I am trying to prove 
the point that it is important to criticize medical science from a social science perspective. By 
doing so, I want to also contribute to the discussion about the interplay of social and natural 
science.  
In general, I think that natural science affects society in many ways. In western society, it 
determines what we define as truth, since everything that can be proven by “hard” science1 is 
considered as a fact. The same might apply to medical science. I personally find that the 
pharmaceutical industry has not received enough attention from the social sciences, which is 
rather surprisingly as the industry plays an important role in global trends such as globalization, 
commercialization and so on. Therefore, this thesis is looking at the industry as a major global 
force in health care on the one hand, and as a producer of knowledge from a social science 
perspective on the other hand. Being one of the main creators of medical facts, I found it very 
important to look at how these medical facts are created, and specifically how new drugs are 
produced. Drugs seem to be an important component of most peoples’ lives, without them even 
realizing it. There is a huge variety on drugs available on the market; and a pill can be a very easy 
and quick solution to physical but lalso mental problems. It is interesting how those pills can 
                                                
1 By “hard science” I mean natural science as opposed to “soft science”, by which I basically mean social science 
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determine the way we think about health and illness, and how pills became a very important 
components peoples’ everyday life. When I started my research on this issue, I discovered that 
there is a term that describes the increasing infiltration of pills into our lives, it is called 
Medicalization.  
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Introduction 
 
Our diseases are so old fashioned,  
they can't keep up with the new medicines 
Leonid S.  Sukhorukov in  “All  about  every th ing” 
 
 
This thesis will apply theories of medicalization to the discourse on medical knowledge-
production under neoliberal conditions. I am going to identify the pharmaceutical industry as one 
of the most important actors in the discourse and the theory and also as one of the main drivers 
of medicalization as well as biomedicalization. I will argue that the neoliberal system provided the 
pharmaceutical industry with favorable framework conditions to bring new drugs to the market 
while at the same time “produce knowledge” to boost their sales. After identifying the current 
trends in the literature regarding the main discourse (that is knowledge production under 
neoliberal conditions) I am going to make attempts to link those trends to theories on 
medicalization.  
The most important goal in the free-market economy is economic growth. Public Health 
is a necessary precondition for this growth. Thus, public health can be seen as a particular 
important concept since industrialization, as countries constantly compete in productivity. In 
order to trace the relationship between politics, science and health I am going to look into 
historical roots of the Biomedicine starting with the enlightenment, which is the dominant 
approach to health and medicine in our contemporary western society and which policies lay the 
ground for medicalization. The biomedical approach has led to a scientificaion of health, which 
made the pharmaceutical industry and the carrying out of their clinical trials one of the most 
important actors in health care in western society.  
The United States are identified as the main driver of medicalization in most of the 
literature. Thus, I will mostly draw on examples from the United States, not only as a main driver 
of medicalization but furthermore as a main driver of neoliberal politics. I will analyze the global 
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trends of health in relation to politics and the economy such as the commodification of health, 
the individualization of health and the scientification of health. These are all trends that have 
emerged in a new global economy that emphasizes the free market economy which I am going to 
refer to as a neoliberal economy. Information strategies, public relations and the role of the 
media in general play an important role not only in drug development and clinical trials, but also 
for direct-to-consumer advertising of pharmaceuticals, which is illegal in some countries but 
definitely an important instrument in the United States. Patients have been turned into 
consumers. In a lot of cases the media tries to convince people that they are suffering from a 
certain kind of illness and encourages them to go to a doctor and ask for the particular product, 
or simply buy it if it is description free.  
The knowledge produced by the pharmaceutical industry is an interested knowledge, 
interests of the private industry such as financial profit, the interests of doctors for reputation 
and interests of the governments that struggle with the increasing costs of health care. The 
pharmaceutical research has turned almost everyone into a potential patient - everyone is 
constantly at risk to fall ill as potential risk factors are promoted for more and more areas of 
people’s lifes.  
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Theoretical Approaches and Research Question  
 
 
The theoretical approaches used in this thesis is firstly given by the biomedical approach 
to health, which is the most dominant approach to health and the body in the “western” world. 
The biomedical approach to health basically separates the body from the non- body, and tries to 
explain everything that is happening in the human body and mind, using western, natural science. 
Furthermore, the approach ignores any social circumstances as a reason for illness or disease and 
looks specifically only at the individual and its body. As a consequence, medical treatments are 
exclusively either pharmacological or clinical.2 The biomedical approach has established itself 
during the enlightenment, which was the time when western thinkers started their search for an 
objective and absolute truth using natural science methods. And why would the human body be 
an exception? Everything that is happening in the human body needed to be explained 
objectively and statistically, which led to the buildings of hospitals to give medical experts the 
chance to observe the patients. With the industrial revolution public health became important for 
economic productivity, and that marks the beginning, according to Foucault, of biopolitics. I will 
analyse the relationship of health and politics in this thesis mainly in the context of first 
capitalism in general and later neoliberalism and the biomedical approach, looking mainly at how 
capitalism has influenced and changed this approach. 
Secondly, and within this framework of the biomedical approach to health, the discourse 
of knowledge production in general and biomedical knowledge production in particular will be 
the second main theoretical focus of this thesis. The production of knowledge in western society 
has changed a great deal under neoliberal economic and political influences, with the political 
power of the state being reduced and the power of the private industry being increased. 
Knowledge production and research nowadays is highly influenced by the interests of the private 
                                                
2 Filc, Dani.: “The medical text: between biomedicine and hegemony”, Social science & medicine, 2004, vol. 59, 
1275-1285, 1276 
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industry and very intertwined with the dynamics and developments of the market. Nowotny et al. 
call it “mode 2 knowledge”. A kind of knowledge that is been created by a mix of private and 
public research institutions and influenced by various interests of both sides.  
Most of the literature I am going to look at how knowledge production has changed over 
time with being more and more influenced by various demands of society and different political 
circumstances. At the same time, I want to question where these changes and demands are 
coming from.  
My perspective in this thesis is a global one  – meaning that my analysis of the biomedical 
approach, medicalization and knowledge production will specifically look at how global trends 
such as neoliberalism, globalization and commodification are related to the developments on 
health and health care on a political and on an economic level. Thus, I mainly look at global 
trends within the given theoretical framework and apply them to the medicalization theory. The 
main geographical focus of this thesis will be “the west”, meaning Europe and North America. 
As I identify the United States as the main driver of neoliberal policies and the country with the 
largest pharmaceutical industries, I will mostly draw on them to provide examples. However, the 
main goal of this thesis is to contribute to the discussion on neoliberalism and health on a global 
level.  
After having identified the current trends in the literature on knowledge production using 
literature review I will link this discourse of knowledge production to the Medicalization Theory. 
Such a link has not received explicit attention so far in the literature. In other words,  
medicalization and biomedicalization have both been described in relation to politics in the 
literature, the link to knowledge production and to the neoliberal system has never been made 
explicitly so far, thus I see this is my contribution and as the main purpose of my thesis. Thus my 
research question can be framed as follows: What role does the pharmaceutical industry play in 
medicalization and biomedical knowledge production under neoliberal conditions? In other 
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words, how does neoliberalism contribute to the process of medicalization with pharmaceutical 
industries as major actors? 
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Definitions 
 
Biomedic ine  
 
Biomedicine is the dominant approach to health and illness in western society. Filc argues 
that “Biomedicine considers illness and disease to be located in the individual and views 
treatment as predominantly surgical or pharmacological.”3 However, the main focus of this thesis 
is not so much on what biomedicine actually is in scientific terms, but more what it represents. 
Its most important attribute probably is the separation of body and mind resulting out of a solely 
(natural) scientific approach to the body and its wellbeing. In the biomedical approach, the 
particular social context of the individual plays no role at all in most cases. 
 
Medical izat ion  
 
In contemporary literature, the term medicalization is usually used to describe the 
increasing infiltration of medicine or medical treatments into more and more areas of peoples’ 
lives. According to Conrad “Medicalization describes a process by which nonmedical problems 
become defined and treated as medical problems, usually in terms of illness and disorders.”4 Peter 
Conrad initially started with his approach in the 1970s by looking at medicine as replacing 
religion (as his first work was called “From Badness to Sickness”, mainly because “bad behavior” 
like alcoholism, drug abuse, abortion and so on affected the health of the individual). The central 
paradox of the medicalization critique is that medicine in western societies has “increasingly 
amassed power and influence.”5 The main focus of this thesis is not to identify medicalization in 
a descriptive way, but rather to apply medicalization as a theoretical approach to contemporary 
knowledge production and the role of the pharmaceutical industry.   
                                                
3 Filc, 1276 
4 Conrad, Peter: “The Medicalization of Society”, Baltimore, 2007, 4 
5 Petersen, Alan / Bunton, Robert: “Foucault, Health and Medicine”, London, 1997, 95 
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Global izat ion 
 
The goal of this thesis is not to define or analyze globalization per se. I will be referring to 
globalization mostly in an economic sense, looking at how globalization is linked to the growth 
and power of the pharmaceutical industry as a global, economic actor. I am not at all denying that 
globalization is a development that embraces much more than the global economy.  In general, I 
prefer Scholte’s definition who argues that globalization is “the spread of transplanetary (…) 
connections between people.” 6 However, most important for this thesis is the relation between 
globalization and the capitalistic system, or the economic aspect of globalization.7Globalization 
increases the global trade and contributes to the spread of free-trade policies. This plays an 
important role in medicalization as it provides the pharmaceutical industry with advantageous 
conditions. Scholte argues that the “intense globalization of the past half-century has substantially 
strengthened the position of capitalism as the prevailing world structure of production.” Thus, I 
will be referring to globalization mostly in relation to economic developments.  
Neol ibera l i sm 
Initially, I tried not to use the term neoliberalism in this thesis, as there are lots of 
different meanings and preoccupations attached to it. Lately the term has been used throughout 
literature in a variety of ways, and sometimes very loosely. In this thesis, the term “neoliberalism” 
is used to define the current political and economic trends in which the private industry plays an 
increasingly important role on the global agenda within the framework of which industries like 
the pharmaceutical sector have a significant influence. This is a main feature of neoliberalism and 
its core assumption of a self-regulating-market. The state is not supposed to “interfere” into the 
market mechanisms. Furthermore, neoliberalism is also crossing the boarders of nation states, 
global actors like World Trade Organization or the World Bank are the most powerful actors in 
                                                
6 Scholte, Jan Aart: “Globalization: A Critical Introduction”, London, 2000, 424 
7 ibid., 159 
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promoting free trade and thus, neoliberalism. This is crucial for my analysis on the main actors 
contemporary medical knowledge production and trends such as globalization or 
commercialization. In other words, I identify my approach to neoliberalism with the following 
definition: “Neoliberalism is in the first instance a theory of political economic practices that 
propses that human well-being can best be advanced by liberating individual entrepreneurial 
freedoms and skills within an institutional framework characterized by strong private property 
rights, free markets, and free trade. The role of the state is to create and preserve an institutional 
framework appropriate to such practices…. Furthermore, if markets do not exist (in areas such 
as land, water, education, health care, social security, or environmental pollution) then they must 
be created, by state action if necessary.”8 
 
                                                
8 Harvey, David: “A Brief History of Neoliberalism“, Oxford, 2007, 2 
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State of the Literature 
 
 
There is no doubt a high amount of literature on health and society in general. As for the 
sociological approach, Foucault has started a huge discourse on health, medicine and power. In 
his book “The Birth of the Clinic”9 he is highly questioning the role of doctors and the clinic as 
an social institution as such, arguing that medical knowledge gives doctors a lot of power 
basically putting patients in a situation where they simply have to trust their medical expertise and 
are being observed 24 hours a day. Even though Foucault is not a key sources for this thesis, it is 
important to mention him at this point as the whole discourse on health and society is mainly 
influenced by his writings, and gave rise to newer theories on medicalization.  
Peter Conrad is one of the first ones mentioning medicalization and by that finally giving 
the increasing infiltration of drugs into peoples’ lives a name. He started the debate in the 1970s 
with his book “From Badness to Sickness” arguing how medicine has replaced religious believes. 
He continued his theories with his newer book “The Medicalization of Society:  On the 
Transformation of Human Conditions into Treatable Disorders”10, which is an excellent source 
demonstrating how the pharmaceutical industry influences the understanding of health through 
the media, always promoting the newest treatments and drugs available. With his book Conrad 
was very influenctial the discourse on medicalization, as he is mentioned in almost every text that 
is written on medicalization.  
 The discourse of knowledge production is one that has mostly been triggered by Gibbons 
et al. “The New Production of Knowledge. The Dynamics of Science and Research in 
Contemporary Societies”11 in which they analyze the very complex system of contemporary 
knowledge production. They illustrate how knowledge production nowadays is highly influenced 
                                                
9 Foucault, Michael: “Die Geburt der Klinik. Eine Archäologie des ärztlichen Blicks”, München, 1973 
10 Conrad, Peter: “The Medicalization of Society”, Baltimore, 2007 
11 Gibbons, Michael / Limoges, Camille / Nowotny, Helga / Schwartzman, Simon / Scott, Peter / Trow, Martin: 
“The New Production of Knowledge. The Dynamics of Science and Research in Contemporary Societies”, London, 
1994 
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by various actors, interests group, and lobbies. Even though their illustrations might be vague at 
some points, their writings were important for me to simply demonstrate that there are different 
interests playing into knowledge production; and as we are living in a capitalistic system, those 
interests might be driven by the aim of financial profit.  
 There is more than enough literature on the pharmaceutical industry, especially on all 
kinds of scandals that have occurred in the past 50 years or so. However, the goal of my thesis is 
not to accuse the industry of being bad or evil, but rather to analyze it as being an important 
actor in medical research and knowledge production. The literature on this is very rare. Andrew 
Lakoff’s “Pharmaceutical Reason: Knowledge and Value in Global Psychiatry”12 is looking at a 
specific case in Argentina, to demonstrate how pharmaceuticals can be a tool to spread the 
economic logic of capitalism around the globe. I chose this book to illustrate the 
interconnectedness between economic power, ideology and health as a personal notion and a 
concept of society.  
As the link between knowledge production and medicalization has not really been made 
so far in a lot of the literature, it is a lot of very specific texts that provide very important sources 
for my research.  A key source is for sure Clarke et al.’s text “Biomedicalization: Technoscientific 
Transformations of Health, Illness, and U.S. Biomedicine”13. Clarke et al. are some of the very 
few authors that really brings together drug development, society’s notion of health, the 
pharmaceutical industry and neoliberalism. Adele Clarke from the University of San Francisco is 
working on a new book on the topic that will be published by the end of this year. She was so 
kind to email me some of the texts and I really appreciate her help and support. Her article is 
only a few years old, but has already triggered a new debate on biomedicalization, which is, in her 
words, the new level of medicalization.  
 
                                                
12 Lakoff, Andrew: “Pharmaceutical Reason: Knowledge and Value in Global Psychiatry“, Cambridge, 2005 
13 Clarke, Adele / Fishman, Jennifer / Fosket, Jennifer / Mamo, Laura and Shim, Janet: “Biomedicalization: 
Technoscientific Transformations of Health, Illness, and U.S. Biomedicine”, American Sociological Review, April 
2003, Vol. 6, 161-194 
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1. Knowledge Production under Neoliberal Conditions 
 
          According to contemporary literature, knowledge is always context-driven, in other words, 
influenced by the interests of society. Research is apparently always on the basis of knowledge 
production. Thus, it is important to look at who is doing the research that produces knowledge 
and how this research is done. Universities used to be the most important institutions for 
research and therefore knowledge production since the enlightenment. However, this has 
changed a great deal under the growing influence of the capitalistic system on politics and society. 
Contemporary neoliberal politics, promoting the free-market economy are carrying this to an 
extreme, which means that research nowadays is highly influenced by the interests of the private 
market.  
A new discourse about this new knowledge production emerged in the 1990s, mainly 
triggered by Gibbons et al., who referred to this new kind of knowledge as “mode2-knowledge”.  
They point out how knowledge production remains no longer unaffected from the demands of 
society, economy, culture, politics but is increasingly embedded within them. In other words, 
knowledge is apparently always predisposed. Gibbons et al. argue: “Such knowledge is intended 
to be useful to someone whether the industry or government, or society more generally and this 
imperative is present from the beginning. Knowledge is always produced under an aspect of 
continuous negotiation and it will not be produced unless and until the interest of the various 
actors are included.”14 
This means that knowledge is not only the outcome of various interests, but very often, 
the whole process of knowledge production is from the beginning meant to go into a certain 
direction, promoting a particular interest. A very provocative assumption made in literature is 
that sometimes the results of research are there before the research is even done, one just has to 
look “long” or “carefully” enough. Doing research requires funding, which means that one has to 
                                                
14 Gibbons et al., page 4 
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look at what kind of research is funded and what is not. In other words, a particular kind of 
research might be done, but another one not, always depending on if there are stakeholders who 
have an interest in a particular research.  
If research is finally undertaken, the question that becomes important is that of who is 
funding the research. In neoliberal dominated times, gradually more companies and industries are 
run privately, but also universities become increasingly dependent on private funding or have to 
collaborate with the private sector. This means that in the long run, more knowledge is produced 
with the aim of making financial profit, because in the end, making financial profit is usually the 
goal of a private enterprise.  
 
1.1  Research and Knowledge  Product ion  
 
Western society is characterized by strong belief is in natural science. Developing out of 
positivism, it is the believe in“objective” research methods to create “truth” that is considered as 
most valuable. Douthwaite et al. argue that “Practitioners of hard science (e.g., most natural 
scientists and some social scientists) are trained to believe that the world they experience has an 
independent reality that they are discovering in their experiments.15 
Scholte argues that current dominant knowledge is a “rationalist” one which has a “scientist 
character”. “[…] it holds that phenomena can be understood in terms of single incontrovertible 
truths that are discoverable by rigorous application of objective research methods.”16 
Neoliberal politics have evidently led to an increase in the privatization of research 
institutions and in private funding for research in general. Universities are by far not the only 
producers of knowledge anymore. Gibbons et al. observe the “ increase in the number of 
potential sites where knowledge can be created; no longer only universities and colleges, but non-
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university institutes, research centres, government agencies, industrial laboratories, think-tanks, 
consultancies, in their interaction.”17 
Furthermore, even if knowledge is produced at universities, this does not mean it is 
produced unimpaired, because, as illustrated before, universities nowadays are supposedly far 
from being independent themselves.  Universities are influenced by neoliberal demands. 
Nowotny et al. refer to it as the contextualization of knowledge. They distinguish between the 
traditional university and the so called corporate universities. Corporate universities are usually funded 
completely by the private industry. Although a distinction between the traditional university and the 
corporate university can probably be made, there is also a collaboration between the two in terms of 
research, which makes knowledge in a traditional university context-driven as well. Both types of 
universities demand each other. Nowotny et al. reason this demand as follows: “The first form of 
corporate university is the other side of the coin to the entrepreneurial university, or the 
traditional university which attempts to reach out into the wider knowledge economy. Both are 
based on the principle of corporate-academic, and generally private-public, partnership.”18 
 
1.2 Knowledge  Product ion and the Market  
 
If private funding or private partnerships play a role in a research process, the invisible 
hand of the market - to use the words of neoliberal philosophy - purportedly dictates partly what 
kind of knowledge is produced. Coming back to my argument that research is only done if there 
is a stakeholder with an interest in it, research for the pharmaceutical industry might be a good 
example. In the case of pharmaceuticals, the goal of most research is apparently to bring a new 
drug on the market. More research is evidently done for widespread diseases or illnesses, because 
it would be most profitable. This means that for rare conditions, satisfying treatment might not 
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be available. This means that the number of patients determines the number of research that is 
done. In private health care systems, the patients are representing the potential market for the 
pharmaceutical industry, as they are the ones being prescribed the drugs. Thus, I claim that by 
neoliberal influences, the knowledge production is increasingly market driven. As pointed out 
before, knowledge is increasingly produced with the aim of making financial profit. This means 
that the success of private enterprises is determined by the quality of their research. It is a current 
struggle of acquiring more, better or newer knowledge - in order to compete on the international 
market. As Nowotny et. al argue that “Specialist knowledge is often a key factor in determining a 
firm’s comparative advantage.”19  
However, not only do companies seek the newest available knowledge, but knowledge is 
“increasingly generated in the market nexus itself.”20 The market drives knowledge production on 
the one hand, but on the other hand the demands of the market change also with new knowledge 
generated by private companies. To give an example for the case of pharmaceuticals: A new drug 
is usually created for a disease or illness that demanded a treatment. The drug is then produced  
in order to bring it on the market and make financial profit. However, it also works the other way 
round, meaning that a new illness or disease is detected by doing drug research. The market 
might demand a new product, or a new drug demands a market. At the end of the day, the aim of 
privately funded research on new drugs is financial profit. A big part of our capitalist system is 
operating on the stock market, which brings the dynamic of market driven research to the next 
level. If a company has an idea, a vision, it has to find investors first to finance the research. This 
means that a product can be brought on the stockmarket before the research is even done. All 
the pressure is then put on the shoulders of the company to make sure that the newly developed 
product is a success. In the case of pharmaceuticals, as I will illustrate later, this becomes 
particularly crucial in clinical trials. Nowotny et al. describe this dynamic of the stock market as 
“insubstantial promises”:  
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“Today insubstantial promises, which are based upon a potential that is difficult to assess 
properly and which will take time to develop fully but which are amplified through the media, 
excite the imagination of industry and the public and influence decisions about which parts of 
basic research are to be funded and which lines of inquiry are to be pursued (…)”21 They also 
point out the role of the media and the whole stock market dynamic. The stock market is of 
course highly influenced by the media, thus, companies need good communication strategies that 
give out the right information at the right time. I am going to deal with the role of the media in 
chapter four.  
 
1.2.1 Commercialization of Knowledge 
 
As illustrated before, under neoliberal influences, knowledge is increasingly exploited for 
profit oriented by private companies. As Clarke et al. argue, “Trends in corporatization and 
commodification are embodied in the moves by private corporate entities to appropriate 
increasing areas of the health-care sector under private management and/or ownership.”22 
This means that knowledge production is not only produced within market-driven institutions, but 
also knowledge that has been produced independently can be exploited for profit-interests. In 
other words, knowledge can be an important tool in order to make financial profit. Social 
sciences, for instance, can provide information on what the society needs or wants by research 
such as opinion polls. This research then influences the market on what kind of products the 
society might be interest in, and thus, social sciences can be misused by the private industry to 
justify the marketing of new products. However, this works both ways of course. If a study 
showed that lots of people would be interested in a certain product, this could be used for 
advertising, making people think that they need it as well. New innovations and new products are 
necessary for companies to survive. Social science is important for the industry in order to find 
                                                
21 Nowotny et al., 38 
22 Clarke et al., 167 
   - 19 - 
out what people want and what they would buy. In other words, to fulfill new needs of the 
society or creating new ones. Nowotny et al. argue: “Successful innovation is now seen to require 
solutions to problems which demand the knowledge and skills not only of the natural sciences 
but also the social sciences and even the humanities.”23 
The commercialization of knowledge triggered debates on the possession of knowledge 
such as debates on intellectual property, which became an important issue on the global agenda. 
Especially in, so to say, a globalized world, with a knowledge transfer between all countries, it 
becomes increasingly difficult to determine which knowledge belongs to whom. However, the 
debate about Intellectual Property is not the issue in this thesis, although it is very important 
especially in the context of pharmaceuticals.   
 
1.3 Global izat ion,  Research and Knowledge  Product ion 
 
Like most of the other private industries, the market of the pharmaceutical industry has 
extremely shifted since the 1980s towards a formation of larger and fewer companies. These large 
transnational companies are doing their medical research on a global scale, in various countries 
and collaborate with various kinds of research institutions, public, private or a mix of both.  This 
increased economic privatization is one of the many features of an economic globalization.  
The power shift from public organizations to private ones is a global trend of the early 
20th century. This is particularly interesting in the case of pharmaceuticals, as in most countries 
health care is a complicated interplay between the private market aiming for financial profit and 
the public sector struggling with exploding costs of the health care system. Clarke et al. refer to 
all institutions with an interest in profit in the health care sector as the Biomedical TechnoService 
Complex: “For the current biomedicalization era, we offer a parallel concept—the Biomedical 
TechnoService Complex, Inc. This term emphasizes the corporatized and privatized (rather than 
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state-funded) research, products and services made possible by technoscientific innovations that 
further biomedicalization.”24 
This TechnoService Complex benefits from globalization as the communication between 
various research institutions is easier with global communication technologies. However, the 
pharmaceutical industry is also highly influenced by the challenges globalization brings especially 
the high competition between companies on the world market, rather than on a national market.  
To sum up, the influence of globalization on knowledge production is two folded. On the one 
hand, globalization makes a better collaboration between research institutions possible, but on 
the other hand, it increases competiveness between them. Companies are operating on a global 
scale. As Nowotny et. al argue: “To compete in world markets mature, as well as leading-edge, 
firms must constantly add to their own stock of knowledge and have instant access to it.”25 This 
means that globalization pushes knowledge production forward, however, the value of this 
knowledge for society is questionable.  
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2. Biomedicine, Politics and Society 
 
The biomedical approach to health has developed under specific economic and political 
circumstances and has permanently influenced our whole understanding of health. As defined 
earlier, biomedicine is the dominant approach to health and the body in the western world, 
exclusively looking at physically explainable diseases and illnesses.  Thus, tracing some of these 
conditions in relation to the history of biomedicine is important at this point in order to 
demonstrate why the biomedical approach became the dominant one in the western context. I 
am arguing that health can be socially constructed and is always embedded in aggregates of 
power.  
 
2.1 Histor i ca l  Background:  The “Rise” o f  Biomedic ine 
 
A strong political approach to health emerged for the first time in the 17th century. 
Politicians struggled with the spreading of diseases, especially in the metropolitan areas where 
there was a lot of poverty. Especially the black death in the 14th century has shown that bad living 
conditions can possibly be responsible for the spread of diseases 26. As a consequence, a set of 
rules for usually preventative health care measures has been introduced by sovereignties, simply 
arguing that better hygiene means a decrease in infection rates. The plague has proven that 
diseases and illnesses weaken the population. This causes a financial deficit in an industrialized 
country in the long run, as the productivity of a state is dependent on the population. Thus, it 
might be fair to say that with the industrialization, health care became the concern of the state, 
simply because a healthy population meant a better productivity in the long run.  
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This political intervention of the state into the health of its population is what Foucault 
refers to as “Biopolitics”27, which is a form of political “control” over the population’s health, in 
the form of peoples’ sanitation, birth control etc. The governments were able to do so because 
they assumed that they had the necessary knowledge about health and diseases, which the 
population did not have. This concept of knowledge is what Foucault refers to as “Biopower”. 
Biopower is the power to control life and death of the population made possible through 
knowledge. This is an important point for the link that I am going to make between knowledge 
and power regarding the pharmaceutical industry and its medical knowledge production in the 
following chapters.  
 
2.2 The Sc ient i f i cat ion o f  Heal th 
 
The 19th century was characterized by a strong faith in healing illnesses and diseases, rather 
than prevention28, because of the strong belief in natural science, which was dominant in the 
western world since the enlightenment. Natural Sciences were apparently the most important 
source to explain how the world works and in search for the truth they had to fulfill the task of 
explaining the real world. The importance of natural sciences in the medical field gave way to the 
entirely mechanical approach to the body. The Cambridge World History of Human Disease 
states: “During this century, the body came to be viewed as something like a machine governed 
by physical principles.”29 This also explains why the Western, medical system, or the biomedical 
system, became the dominant medical system, as opposed to the Ayurvedic or Chinese medical 
system. Whereas in Western medicine, a healthy human being is simply someone not suffering 
from any illness or disease, the Auyurvdic system always claimed from the very beginning ,that 
“The primary objective of the science of life was the maintenance of health, rather than the 
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treatment of disease. Health was not simply the absence of disease, but a state attained and 
enjoyed only by vigorous pursuit of an elaborate, individualized program of prophylactic 
measures prescribed by the Ayurvedic doctor.”30 
Most influential on western, medical thinking even before the enlightenment was Rene 
Descartes, who treated body and mind as something that can be separated.31 “Cartesian man had 
a dual nature: a physical body ruled by universal laws of matter and motion, an immaterial soul or 
mind- a pure thinking entity-located in the pineal body of the brain.”32 
 This mind-body dichotomy of Descartes can be seen as the foundation for the 
intensification of a mechanic approach to the body and was later adopted by enlightenment. The 
body has been separated from the mind, which means that any illness or disease is tackled with 
purely scientific, biomedical methods of treatment. It was also what David Armstrong refers to as 
the starting point of surveillance medicine. Surveillance medicine is probably a necessary part of the 
western, biomedical system and the classification of symptoms. Armstrong argues: “In the early 
eighteenth century, under a regime of Bedside Medicine, illness was coterminous with the 
symptoms that patients experienced and reported.”33 By the definition of symptoms, the 
interpretation and the link to illness and disease, as a “clinical picture”34 could be drawn in order 
to identify a person’s medical problem. From that moment on, health and illness was only 
addressed physically, which is the most important feature of Biomedicine and distinguishes it 
from other medical systems.  
  
2.3 Chal l enges  o f  Global izat ion to  Heal th 
 
Globalization brings new challenges to the political approach to health. New diseases 
emerged with the mobility of people and diseases spread more easily and quickly. A good 
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example is the European countries’ struggle with cholera in the mid-nineteenth century. The 
spread was caused by the increasing international trade and migrations brought by the 
industrialization of the world economy. Industrialization improved transportation technologies, 
and the need for raw material caused a massive increase in migration flows. “Hardly any corner 
of the earth was untouched by migration.”35 The rapid movement of people, goods, services and 
capital brought many demographic challenges; the size of human populations was changing as 
well as patterns in migrations and settlements. Pappas et al. argue: “The movement of two 
million people each day crossing national borders and international commerce is inevitably 
associated with transfers of health risks.”36 
Furthermore, globalization causes an increasing gap between rich and poor, which might 
make people want to migrate in the first place. People from poor areas migrate in order to find 
work, usually to big cities rather than to rural areas, which explains the trend of urbanization. In 
other words, industrialization caused urbanization. With more people living on the same spot, the 
danger of disease spread increases.  
Infectious diseases are by now a leading cause of premature mortality not only in 
developing countries, but also in the developed countries. This in turn gave rise to the need for 
more and better medical treatment and also immunization for people who travel to other places, 
both being of course a big market for the pharmaceutical industry. Thus I argue that globalization 
increased the power of the pharmaceutical industry.  
A healthy population has been seen as the prerequisite for productivity since the age of 
absolutism. Now, it is not only nation states competing but also multilateral players like the 
European Union competing on the world market. The 2007 White Paper of the European Union 
points out how important the link between health and economy is. Principle 2 emphasizes the 
need for a “Development of a programme of analytical studies of the economic relationships 
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between health status, health investment and economic growth and development”37. 
Apparently, public health is not only seen as interlinked with economic growth, it is 
regarded as precondition for economic growth. The very first sentence of Principle 2 that 
“Health is the greatest Wealth”, highlights health as a necessary precondition for economic 
growth. “Health is important for the wellbeing of individuals and society, but a healthy 
population is also a prerequisite for economic productivity and prosperity.”38 The economy plays 
the most important role on the world agenda, and this very much influences the political 
approach to health. Furthermore, it changes the personal notion of health, as being productive is 
now equalized with being healthy.  
 
2.4 Biomedic ine and the Personal  Notion o f  Heal th 
 
 
Since Foucault, there seems to be a common understanding in postmodern literature that 
our understanding of health always has to be seen as a notion subject to change within many 
different complexes of power. Interestingly, while the anthropological concept of health 
recognizes the different notions of health in different societies, the political definition of health 
(usually in regards to health care or in the development context) is often very one-dimensional. 
Levin et al. argue: “International public health advocates (no less than clinicians in industrialized 
countries) continue to conceptualize Health as the absence of disease and infirmity, and as a kind 
of ‘‘default’’ condition that inheres when an individual manifests neither symptoms nor clinically 
measurable abnormalities.”39  
Looking at this definition immediately raises the question of how these symptoms or 
abnormalities are defined. As Levin et al point out, the symptoms have to be measurable, which is 
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the overall approach to health in western biomedicine, being able to measure everything. Only then 
is something approved as a scientific fact.  The approach also highlights the importance of 
natural sciences and the dominance by a mechanical approach to the body. However, health is 
conceptualized differently in different societies. Levin et al. argue that different cultures have 
different notions of health, thus their definition applies to the common “western” understanding 
of health.40 
In contemporary societies, health as a personal notion is very much influenced by health 
care politics and the economy. Health care policies determine what is to be considered as illness 
and what might be a valuable treatment. Advertisements tell us how to be healthy and what is 
considered as a healthy lifestyle. Neoliberal politics shift more and more political power to the 
private industry, thus the economy plays a more and more important role in defining health as 
well. State and economy became much more intertwined in healthcare, especially in the form of 
lobbies.  
In the free-market-economy, the media penetrates people constantly with suggestions on 
how to live a healthy life. It promotes the right choices in nutrition, the importance of taking 
vitamins and having yourself checked by the doctor for illnesses or diseases. The effort of 
governments in regards to health is summarized under the term public health. Governments can 
intervene in preventative health care measures, like the teaching of sports in schools, financial 
support for physiotherapy, prohibiting smoking in public places and so on. McMichael et al. 
define Public Health as “the art and science of preventing disease, promoting health, and 
extending life through the organised efforts of society”.41 In this definition, the main actor is “the 
society”. However, it always depends on who holds the power in the particular society. 
Nowadays, it is mostly a mixture of government, lobbies, economy, Non-Governmental-
Organisations and so on. Thus, this could mean that any concept of health, as a personal or 
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political term, may be flexible and might change depending on what constitutes the particular 
society.  
 
2.5 Heal th Care and Neol ibera l i sm 
 
 
Concluding from the previous chapter, health as a personal notion is always subject to 
change with the circumstances, particularly the values that are promoted by those who have the 
political power and medical knowledge to do so. According to Osborne, “health is not an 
absolute or determinate concept but an essentially indeterminate, relative or elastic one.”42  In 
other words, health as a perception is accordant to change, depending on the values that are 
constructed by governments.43 Osborne argues: “Because health is not an absolute value, 
neoliberalism attempts to construct values according to a kind of immanent logic-it involves a 
kind of boot strapping of surrogate health-values, targets are set, market-exchanges take place, 
performance is monitored, success and failure rates are measured, new targets are set, further 
market-exchanges take place….” 44   
This means that the personal notion of health is intertwined with the market. The 
neoliberal paradigm evidently shifts the responsibility for health mainly to the individual. As 
Petersen argues: “Neoliberalism is a form of rule which involves creating a sphere of freedom for 
subjects so that they are able to exercise a regulated autonomy….” 45 This freedom gives the 
individual the opportunity to choose out of a variety of health care options, provided by all 
different kinds of actors with medical expertise: Doctors, magazines, the internet and so on. 
However, it is obviously particularly the interests of the market that come through, and the 
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interests of the political government are, as a neoliberal feature, reduced. As Peterson argues: 
“Although expertise still continues to play a crucial role in government, the authority of expertise 
is increasingly separated from the apparatuses of political rule, and located in the market….”46 
Every individual is managing its own health, by choosing out of all different options 
promoted by the private industry.  Apparently, according to this expertise, the individual is 
constantly at risk to become ill; getting the right treatment in case of an illness, as well as doing 
everything possible to prevent illnesses, such as a healthy lifestyle, seeing a nutritionist, reduce 
stress being on the daily agenda. To consult experts for any aspect in life and health is constantly 
promoted by the private sector. As Petersen argues: “In particular, I point to the uncertainties 
generated by the subject’s reliance on expertise which is increasingly located in the free market, 
where the rationalities of competition predominate.”47 
The United States may provide the best example, since they are running an entirely 
private health care system. Most other western countries have a mixed system, for instance with 
basic coverage by the state but with the opportunity to get “better”, private insurance. 
Furthermore, it is always important to look at which treatments are covered by insurance and 
which not. Apparently, scientific tests and clinical trials became the main tools in making 
decisions on this. Risks, effects and side effects are meticulously measured, especially in private 
health care systems, in order to maximize profits. In other words, clinical testing is a key element 
in the biomedical approach.  
Furthermore, people are expected to be fit and healthy in order to fulfill the requirements 
of a “normal” job, which goes back to my arguments on health and productivity in the previous 
chapter. Private enterprises are highly competitive as employees are always expected to be better 
than the competition. A healthy body and state of mind is the necessary precondition for that. As 
Rose argues: “In advanced liberal democracies…..genetics takes its saliences within a political and 
ethical field in which individuals are increasingly obligated to formulate life strategies, to seek to 
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maximize their life chances, to take actions or refrain from actions in order to increase the quality 
of their lives, and to act prudently in relation to themselves and to others.”48  
 
2.6 Economic  Growth,  Heal th and Deve lopment 
 
 
The global economy and its focus on economic growth over the past decades created a 
big gap between the developed countries and the developing countries. The focus on economic 
growth is also intertwined with the political attempts for a better global health. The leading free 
trade organizations of the developed countries have an interest in a better health for developing 
countries, as they rely on their economic productivity. Furthermore, with globalization, diseases 
can spread easier and quicker from poor to rich countries, as the outbreak of SARS in 2003. The 
developing countries on the other hand are dependent on the trade with rich countries, and the 
outbreak of a disease could cause an enormous economic harm if the countries would create 
embargos against them. This means that in many ways, both sides are mutually dependent on each 
other.  
In neoliberal philosophy, economic growth and the health of populations go hand in 
hand. If a country is healthy, it can achieve a better economic growth, and if a country grows 
economically, it can easier achieve a healthy population. The WHO has established new health 
regulations after the outbreak of SARS, the purpose of which  is  “to prevent, protect against, 
control and provide a public health response to the international spread of disease in ways that 
are commensurate with and restricted to public health risks, and which avoid unnecessary 
interference with international traffic and trade.”49 This implementation clearly states the 
importance of the economy to avoid unnecessary interference with international traffic and trade, 
but that also of health.  
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This development approach to health demonstrates once again the priority of economic 
growth in the International Community and the importance of the relation between productivity 
and health.  
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3. Medicalization 
Medic ine ,  the only profess ion that 
labours incessant ly  to destroy the reason 
for  i t s  exis tence  
James Bryce
  
 
3.1 A his tor i ca l  approach to  Medica l izat ion 
 
In contemporary literature, the term medicalization is usually used to describe the 
increasing infiltration of medicine or medical treatments into more and more areas of peoples’ 
lives. According to Conrad, “Medicalization describes a process by which nonmedical problems 
become defined and treated as medical problems, usually in terms of illness and disorders.”50 
Peter Conrad initially started with his approach in the 1970s by looking at medicine as replacing 
religion (as his first work was called “From Badness to Sickness), mainly because “bad behavior” 
like alcoholism, drug abuse, abortion and so on affected the health of the individual. The 
medicalization critique arose initially in the sociological literature from Marxist perspectives and 
was “one of the most dominant perspectives in the sociology of health and illness in the 1970s 
and into the 1980s”51. The central paradox of the medicalization critique is that medicine in 
western societies has “increasingly amassed power and influence.”52.  
Critics in the 1970s such as Irving Zola argued that medicine begun to take the role of 
religion. Further critics such as Ivan Illich contended that rather than improving people’s health, 
medicine can be harmful, because of the possible side effects and because it takes away peoples’ 
ability to take responsibility for their own health. Medicalization was further criticizing the role of 
medical experts: “In concert with liberal humanist ideals, critics argue that becoming 
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“medicalized” denies rational, independent human action by allowing members of an 
authoritative group (in this case the medical profession) to dictate to others how they should 
behave.”53 
This debate also plays a role with the question of classes in the sociological theory. 
Disadvantaged groups, “whose lack of power is further entrenched through their interactions 
with powerful doctors who seek to maintain the social status quo.” According to the 
medicalization critique, people with a lack of knowledge simply have to trust the medical experts, 
which gives medical experts power through knowledge. In the medicalization critique patients are seen 
as vulnerable, economically disadvantaged groups, who do not have control over their own 
health.  
Furthermore, the medicalization approach only points out the supposedly negative sides 
of western medicine and claims that most doctors are willing allies of the pharmaceutical 
industry. For that reason, the medicalization critique has largely been criticized for its “black-and-
white portrayal of Western medicine as largely detracting from rather than improving people’s 
health status, of doctors as intent on increasing their power over their patients rather than 
seeking to help them, and of patients as largely helpless, passive and disempowered, their agency 
crushed beneath the might of the medical profession.”54 
 
3.2 Medica l izat ion,  Power and Knowledge  
 
 
Foucault argues that medical knowledge determines what is understood as health and 
what as illness. Knowledge means power. In regards to politics, this means that those who 
establish the rules are also those who have the knowledge. In neoliberal governments, it is usually 
a mixture of political and economic actors that set up those rules. Lupton argues: “From this 
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perspective, medical power may be viewed as the underlying resource by which diseases and 
illnesses are identified and dealt with.”55 
 An interpretation which takes this one step further is that illness and disease can be 
socially constructed by those who have the power to do so. Societal doctrines can be a product of 
political will, shaped by those who have certain interests and the authority. Whoever has 
influential power might determine in the long run what people understand as sick and what not. 
As Lupton argues: “From the Foucauldian perspective, power as it operates in the medical 
encounter is a disciplinary power that provides guidelines about how patients should understand, 
regulate and experience their bodies.”56 Applying Foucault’s arguments on the free-trade era with 
the private sector acquiring more and more power, it means that it is the industry that determines 
more and more our understanding on health. One of the most important private industries in 
regards to health is no doubt the pharmaceutical industry, which undertakes a great deal of 
medical research and health is more and more influenced by the interests of the economy (I will 
go into more detail on this in my case study on medicalization).  
 
3.3 The Shi f t  f rom Medica l izat ion to  Biomedica l izat ion 
 
 
Clarke et al. started a discussuion on biomedicalization in the beginning of the 20th 
century. They see the beginning of biomedicalization in 1985 which they also describe as the 
beginning of late-modernity, with the increasing techno scientific innovations regarding health, 
such as biotechnology. They describe the difference between medicalization and 
biomedicalization as the following: While medicalization regulates areas of peoples’ life that have 
been regulated so far by something else, for instance by religion or governments, 
biomedicalization touches upon aspects in our lives that have been “unregulated” so far, like 
                                                
55 Lupton, 99 
56 ibid., 99 
   - 34 - 
plastic surgery or genetic engineering. The goal is not any longer to heal, it is to make people feel 
better, look different or “improve” their lives in any other way. Rose argues that  “… the field of 
our contemporary biopolitics is not defined by health and illness……It is a space of problems 
concerning the optimization of life.”57 Furthermore, the medical control has shifted, from an 
external one to one of an internal nature. Biomedicalization is transforming “life itself”: “In the 
current technoscientific revolution, “big science” and “big technology” can sit on your desk, 
reside in a pillbox, or inside your body.”58 
Innovations in plastic surgery for instance made it possible for people to change their 
looks with the help of plastic surgery if they do not like something about themselves. This means, 
that not only disease or illnesses are medicalized, but also feelings and desires. Clarke et al. argue: 
“..conditions understood as undesirable ... were medicalized (e.g., unattractiveness through 
cosmetic surgery; obesity through diet medications), and the medical treatment of such 
conditions was normalized.”59 
Biomedicalization is operating on a different scale then medicalization, the global scale. 
There is no doubt a global trend of commodification of health, which contributes to 
biomedicalization as it increases collaboration between all different stakeholders in the health 
care business on a global level, creating the Biomedical TechnoService Complex. It promotes 
health as something that people have to work towards to, but not only by the prevention and the 
risk reduction, but also as something that can supposedly improve life, make it better. With genetic 
engineering, we not only have to avoid risks but the DNA gives us information about what kind 
of illness we might have some day in the future.  This means that we have to live our life 
according to our risks, defined by our DNA. The endless possibilities of genetic engineering 
provide a strong ground to change peoples’ well-being by the infiltration of more and more 
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technology into people’s lives. Thus, it might be fair to say that genetic engineering increases 
medicalization as well as biomedicalization.60  
 
3.4  Indiv idual izat ion o f  Heal th Care  
 
Health care nowadays is very individualized, in the sense that the responsibility to be 
“healthy” is now shifted away from the state to people themselves. There is a big variety of 
options available on the market, not only by picking the right insurance (which is the case for the 
United States), but also consultation in nutrition, cancer screenings, or psychotherapy is 
something that people are supposed to make use of in order to be, stay or become healthy. The 
market promotes individual responsibility as empowerment of the people to take their health into 
their own hands. The empowered patient that makes decisions on his/her own. The first priority is 
to reduce as many risk factors as possible. As Filc argues: “in the field of health care, the focus on 
risk is expressed through an emphasis on the concept of ‘‘risk factors’’ underlying disease at the 
individual level, and the motion of behavioral changes and regular ‘‘check ups’’ in order to 
‘‘diminish risk.”61 Most of these options to diminish risk are embedded in the market, especially 
in the United States with an exclusively private health care system. Health became something that 
can be consumed by people. I will go into more detail on risk and health in the next section. 
In some countries, health insurances are part of the private economy as well, that means 
that health care is even more dependent on the market and embedded in the dynamics of the 
market. Busfield argues: “..…the industry is a major force shaping health care in many societies, 
with the prescribing of medicines a dominant feature of medical care.”62  
It seems that it is almost everyone’s obligation to try as much as possible to become or 
stay healthy. To accomplish that, people are supposed to make use of whatever health services 
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are offered and to consult an expert if needed: Filc argues: “The individual is responsible for 
his/her good or bad health, and is encouraged to monitor his/her health constantly: low 
cholesterol, low-fat, or low-salt diets are recommended as part of a repertoire of healthy 
behavior, as are weight control, exercise, and regular check-ups.”63 
The variety of experts on health is growing every day, people have “personal trainers” who tell 
them when to work out and how, they have a nutritionist who tells them what to do and they see 
a psychologist to feel better about themselves. “Everyday life becomes saturated with expert 
knowledge that advises us what food to eat, what exercise to take, from routine health education 
through to more in-depth therapy. Self-realistaion takes place through more reflexive 
consideration of lifestyle options and life-planning.”64 
 Furthermore, there is a big variety of screenings available that can evidently identify if 
any organ in the body might be at risk. Clarke et al. refer to these techniques as being linked to 
the neoliberal discourse:  “The biomedical governmentality to “know thyself” that is associated 
with such bodily techniques often relies on a neo-liberal consumer discourse that promotes being 
“proactive” and “taking charge” of one's health”65 
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3.5 Risk, Surve i l lance  and Biomedica l izat ion 
 
 
In the biomedical era, everyone is constantly at risk to become ill. The market promotes 
the so-called risk factors for more and more areas of people’s lives. Clarke et al. argue that 
nowadays, everyone is at risk. However, there are different degrees of risk. As Clarke et al. argue: 
“It is impossible not to be at risk. Instead, individuals and populations are judged for degrees of 
risk – “low”, “moderate”, or “high” vis-à-vis different conditions and diseases, and this then 
determines what is prescribed to manage or reduce that risk.”66 Usually, a variety of supposed 
symptoms is identified that goes along with a certain risk. The more knowledge is produced 
about risks, the more risks we are supposedly exposed to. With all the biomedical research, more 
and more “risks” are defined for the individual. Apparently, in our so termed “risk” society, the 
individual is permanently at risk.  This starts in early childhood. Borck argues that it starts in 
kindergarten with medical education on caries and continues on with medical check ups by 
doctors in schools and company physicians. Thus, no area of life is untouched by medical 
surveillance anymore. (translation of the author).67 This constant presence of risks requires even 
more surveillance, but not only surveillance by medical experts, also a constant “self”-surveillance 
is required in order to avoid risks. Armstrong goes one step ahead arguing that it is not 
symptoms that point to the “hidden pathological truth of disease”, but “the risk factor opening 
up a space of future illness potential”68. In other words, symptoms in Surveillance medicine are 
only important as they can be “re-read as risk factors”69. 
Furthermore, the more risks we are exposed to, the more surveillance do we need: “Risk 
and surveillance mutually construct one another: Risks are calculated and assessed in order to 
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rationalize surveillance, and through surveillance risks are conceptualized and standardized into 
ever more precise calculations and algorithms.”70  
In contemporary biomedicine, risk becomes incredibly expanded with genetic 
engineering. The ability to predict the future with genetic screening raises of course a lot of 
questions on identity, confidentiality and so on. An important issue in this context is that genetic 
screening identifies risks for illnesses that might or might not occur in the future. The question 
then becomes what the individual is responsible for in order to reduce the potential risk. As Rose 
argues: “While hereditary knowledge’s have long been associated with various forms of risk 
thinking, the availability of predictive genetic testing introduces a qualitative new dimension into 
genetic risk, creating new categories of individuals and according genetic risk a new calculability. 
As a result of this new knowledge, it is becoming possible for individuals to be identified as 
genetically at risk for a particular conditions prior to any symptoms appearing.”71 
This means that genetic risks would determine how to live one’s life, which of course influences 
the personal notion of one’s health. If genetic screening is the responsibility of the state, it would 
mean that the state influences the decisions one makes about how to “conduct one’s own life, 
have children, get married, or pursue a career.”72 Rose argues further that this goes along with the 
“work on the self in contemporary advanced liberal democracies that construes life as a project, 
framed in terms of values of autonomy, self-actualization, prudence, responsibility and choice.”73  
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3.6 Consequences  o f  Biomedica l izat ion 
 
The role and meaning of medicine for the society has changed a great deal with the 
biomedicalization processes. Obviously, medicine was initially supposed to treat abnormalities of 
the body to make it “normal” again. However, it is now much more than that, because medical 
treatments are no longer only re-acting to abnormalities of the body, medicine is setting the 
standards for what is to be considered as normal or healthy itself. All advancements of the new 
medical technology create new “standards” of what is considered as “normal”. Rose argues that 
“… the role of medicine was not to transform human capacitites but to restore a lost 
normativity….. But these norms no longer seem so normalizing, these normativities appear in 
principle open to conscious manipulation, and new norms created by biomedical artifice are 
already reality.”74 In other words, medical treatment defines what is to be considered as healthy or 
sick. Conrad argues that the “infiltration of biomedicine into everyday life through commonly 
used medical treatments redefines “healthy” and “normal” in regard to bodily function.”75 
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4. The Pharmaceutical Industry and the Production of Medical Knowledge 
 
The pharmaceutical industry is one of the many industries that could obviously benefit a 
lot from the free-market economy as it grew rapidly since the 1980s. Its influence on global 
political agenda is very strong in the form of pharmaceutical lobbies. According to Busfield, the 
pharmaceutical industry is now a “major power within the global economy” and a “major force 
in shaping health care in many societies.”76 Busfield distinguishes between three different sources 
of power: economic, political and ideological power. He says that the pharmaceutical industry not 
only has economic and political power (because of its strong lobbies) but also ideological power, 
meaning that it shapes the society’s understanding of health as such by the development of its 
products. Because the kind of treatment out there can make people identify themselves with a 
certain kind of illness they might have not thought of before.  
All different sources of power influence one another. The greater the economic and 
political power of the industry is, the more it has the chance to produce scientific facts. The 
industry is undertaking a big part of the medical research out there, which can be summarized as 
the industry’s economic and political power. The research that shapes our understanding of 
health is the one that I would call ideological power.  
In 1987 Latour claimed that 70 percent of the research are carried out in industrial 
contexts as opposed to publicly funded context.77 Nowadays, any number would probably be 
hard to confirm, because of the opacity of all kinds of semi-independent research institutions that 
are neither exclusively private nor exclusively public. However, simply looking at the growth of 
the industry itself (which is estimated at about 8 percent year)78, it might be fair to assume that 
the influence on medical knowledge production has grown as well. However, the pharmaceutical 
industry not only produces pills, but also a lot of knowledge on health, medicine and risks in 
addition to producing those pills. Furthermore, it has to be mentioned here that the industry is 
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not only developing the drug, but also doing the research on safety and side-effects, which is a 
main point of Lakoff’s critique. As “pharmaceutical companies are producers not only of pills but 
also of knowledge about their safety and efficiency…”79, it is the industry that provides us with 
information on the effects and side effects of a pill, usually tested in a clinical trial. I will go into 
more detail on clinical trials later in this chapter.  
 
4.1 The Black Boxes o f  Medica l  Research 
 
 
Looking at the production of scientific facts from a social science perspective, Busfield 
draws on Latour’s analysis of scientific “black boxing” in regards to knowledge production in 
natural science. His critique emphazises the lack of attention in social science to the different 
sources of powers that produce scientific facts. In the case of drug related research, the major 
power is the pharmaceutical industry. Thus, it is important to understand the interests that may 
play a role in this research. The black boxes in the case of pharmaceuticals symbolize the drugs 
that have been launched on the market. Once a drug has successfully undergone a clinical trial 
and has been approved as a treatment for a medical condition, the black box is closed, and the 
value of the drug becomes a scientific fact.  
In Latour’s analysis, he argues that more attention needs to be drawn to those sources of 
powers that contribute to this scientific fact making.80 His concern is mainly the “science in the 
making.”81 Who is behind the research? Where does the funding come from? Who controls the 
outcome? All these are very valuable questions in regards to pharmaceutical research. Busfield 
argues: “Viewing pharmaceutical products as new technologies, we can draw on certain aspects 
of Latour’s analysis to examine how the industry contributes to the construction of scientific 
facts about new drugs; how it helps to ensure they are judged safe and effective by drug approval 
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agencies, so closing the black box for many people.”82  
Busfield criticizes the freedom that pharmaceutical companies have in their research and 
clinical trials as well as after a drug has been approved. He argues “once launched onto the 
market, companies are in a relatively powerful position to keep the box closed and to encourage a 
drug’s use, often well beyond its useful boundaries.”83 This again goes back to the fact that the 
private industry gained a lot more power over the past decades, due to neoliberal economic and 
political trends.  
 
4.2 Clini ca l  Tria ls   
 
In order to bring a drug on the market, it usually has to be tested in a clinical trial to 
assure its safety and effectiveness. Clinical trials have come under a lot of critique lately on how 
they are done and their standards of efficiency and safety. However, what I want to criticize here 
is the fact that once a drug has been approved in a clinical trial, it can be launched on the market 
without any further trials in the future. If a drug is approved by a clinical trial, it is considered as 
valuable and its effectiveness as a scientific fact, a black box. Clinical Trials have become an 
efficient instrument in the development and marketing of new drugs.  
Clarke et al. argue that “The randomized controlled trial consisting of three phases of 
testing in human subjects has become the ideal instrument for producing scientific knowledge 
and evidence for therapeutic appropriateness of releasing any drug or medical device onto the 
market.”84 Clinical Trials have furthermore become a big business for the industry, doctors and 
recently investors. Thus, pharmaceutical companies are under a lot of pressure to make a trial 
successful. It is an interconnectedness between a big variety of stakeholders. Rose argues that 
“Conducted at a molecular level, biology and medicine require long periods of investment, the 
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purchase of expensive equipment, the maintenance of well-staffed laboratories, a multiplication 
of clinical trials…Increasingly such investments comes from venture capital provided to private 
corporations, who also seek to raise funds on the stock market….”85 
The knowledge produced here is characterized by the involvement of both private and 
public research institutions, a strong trend of the neoliberal era. Clarke et al. argue that “These 
emergent forms of legitimation contribute to a biomedicalization of clinical trials not only 
through a scientization of the FDA's86 approval process, but also through new linkages created 
among government agencies (e.g., the FDA), private industry (e.g., pharmaceutical companies), 
and academic research institutions.”87 
 
4.2.1 Three Phases of Clinical Trials 
 
Usually, a drug can only be tested on humans if it has been tested on animals before. 
After that, human testing involves three phases. The first phase is the testing on healthy 
volunteers, followed by the second phase, the testing on patients that suffer from what the drug 
is supposed to heal, usually several hundred test persons. The last phase is usually a controlled 
trial, testing the drug parallel to a comparator of placebo88. The testing is usually a very long 
process that takes several years. Once the trial was successful, the efficiency of the drug is 
supposedly proven and becomes a scientific fact, “the black box of complexity that no longer needs 
to opened”89.  
Not only are clinical trials influenced by the interests of the pharmaceutical industry, but 
furthermore “industry academy collaborations are also becoming routine sources of funding for 
universities, including academic medical centers (combinations of medical schools, hospitals, 
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clinics, and research units) that had been federally funded for 30 years.”90 Clarke et al. also argue 
that industry-sponsored research is much more likely to produce results favorable to the 
sponsor.91 
 
4.3 Communicat ing Resul t s  o f  Cl ini ca l  Tria ls  
 
The information given out about results of clinical trials is a major aspect of knowledge 
production, as the results that are communicated to the outside apparently become the knowledge 
that determines the success of a new drug. Lakoff argues: “Information about the efficacy of new 
drugs is intensely guarded because news of the success or failure of drugs in clinical trials can 
drastically affect the price of stock market shares.”92 Again, it is important to look at the different 
sources of power operating behind the trial. Thus, it is important to look at who is 
undertaking/financing the trial. According to Busfield, the pre-approval testing of a drug is 
usually carried out by the pharmaceutical company itself or it is outsourced to other commercial 
companies that are specialized in the testing of drugs.93 This means, that the pharmaceutical 
companies have the power of controlling most of the research in regards to the development and 
testing of a new drug. As Busfield argues: “The industry’s control over R&D means that it plays a 
major advantage when seeking approval for new drugs, including the power to select information 
to support their case and to withhold information might undermine it.”94 
Secondly, it is important to look at the reports of the trials, because they lay down if a 
drug can actually be marketed or not. In other words, the information given out about the trial is 
a crucial part of the whole medical knowledge production process. Busfield argues that one 
fundamental problem in regards to the communication of clinical trials is “the freedom given to 
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companies to demonstrate a preparation’s value by carrying out the studies, selecting the tests 
and presenting the data in ways they choose.”95 Another way to look at it is as a problem of how 
to interpret the data, and there might often be more than one possible interpretation.   
4.3.1 Ghostwriting and Clinical Trials 
 
An unethical instrument of the pharmaceutical industry to publish this information is to 
hire a ghostwriter, who writes a report about a clinical trial of a pharmaceutical company which is 
then published under the name of a hired medical expert, usually key opinion leader in the 
medical field. There are several methods in ghostwriting in order to make a medical trial look 
more successful than it actually was. Firstly, the ghostwriter can raise the right questions in his 
reports from the very beginning, to avoid having to talk about negative results of the trial. 
Secondly, he probably develops a communication strategy before he even starts writing on his 
report. This strategy determines what to communicate to the public and in which way. The 
ghostwriter usually concentrates on the positive outcome of the trial and pays less attention to 
risks or other information that might be harmful to the success of the new product.  
Moffatt et al. argue that the publications of clinical trials are overwhelmingly favorable to 
the sponsor’s product96. For publishing, the company needs a trustworthy and respected opinion 
leader who approves the report. In the case of ghostwriting, he would sign it and even publish it 
under his own name. In some cases, the ghostwriter writes only a little draft and the expert the 
actual article, but sometimes the ghostwriter writes the whole text and the opinion leader simply 
signs and publishes it. In exchange for that, the opinion leader might receive payments, a budget 
for marketing and besides that, being part of a successful clinical trial brings attention in respect 
to medical field.  
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5.  The Link: Medicalization and Knowledge Production in Neoliberalism 
  
5.1 Medica l  Knowledge  Product ion and the Neol ibera l  Market   
 
As I have demonstrated in chapter one, knowledge production under neoliberal 
conditions is highly influenced by the private industry. In the case of medical knowledge 
production in particular, one of those private enterprises is the pharmaceutical industry. It 
became a very influential and powerful actor in the medical global agenda. It might be fair to say 
that the industry is trying to shape the understanding of health to its will, by driving 
medicalization (and biomedicalization processes) in promoting their drugs and producing medical 
knowledge about their effects.  
As the market became a very influential actor in society, it is marketing, that determines 
whether a drug will be successfully sold or not. As I have pointed out before, knowledge 
production nowadays is very intertwined with the market. This market is evidently shaped, 
penetrated and expanded by the pharmaceutical industry, using their biomedical research results 
for advertising their newest treatments. Lakoff cuts to the point saying that: “In the United States 
and Europe, regulatory and professional demands that medication be targeted at a specific illness 
located in the brain shaped the marketing on biomedical “depression” as that which anti-
depressants are meant to treat.”97 He calls it “personalized medicine”, which he thinks will 
determine the future of our health, “an innovation linking production and consumption through 
the invention on a new need.”98 Companies usually advertise their products directly to those 
medical experts and doctors who are in the position of prescribing them. However, there is also 
the “direct-to-consumer advertising” in the United State, that targets the potential patient, 
making people aware of what kind of illnesses they might have. The patient is then encouraged to 
go to the doctor and ask for this particular treatment. 
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 5.2 The Role  o f  Medica l  Experts  in the Product ion o f  Interes t ed Knowledge  
As explained in chapter three on medicalization, the role of medical experts is very crucial 
in relation to power and knowledge. From the medicalizaiton perspective, medical experts are 
very influential in a set of power relations that determines what the patient understands as illness 
or disease, because those are the ones consulting and treating the patients. The Foucauldian 
perspective argues that “it is impossible to remove power from members of the medical 
profession and hand it over to patients.”99Medical Experts (doctors) are very often, as Busfield 
calls them “willing allies of the industry”100 and apparently play a very important role within 
marketing and knowledge production of pharmaceutical companies. The industry tries to 
convince doctors to prescribe their products by inviting them to information events, at which they 
present their research results along with the newest treatments. In return, doctors get the chance 
to become part of these campaigns, which is a good chance to market themselves, as medical 
experts. This means that both sides, the industry on the one hand, and medical experts on the 
other hand, benefit mutually.  Companies use the result of biomedical research to convince 
doctors to prescribe their products. They also fund such research and sponsor travel to 
professional conferences and workshops to disseminate the results- so long as they are 
favorable.101 In other words, doctors get access to particular knowledge, which is biomedical 
research presented by pharmaceutical industries.  
  “In their relations with pharmaceutical companies, then, it is not so much that doctors are 
faced with a conflict of interest between science and the market as that they are embedded in an 
atmosphere of interested knowledge.”102 Busfield argues that it is a balanced relationship of 
giving and taking.  “The industry needs doctors to prescribe its products, and practicing doctors 
need the industry’s products to help to maintain their professional standing and power, a 
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situation enhanced by their near monopoly over prescribing.”103 He goes further and says: 
“Instead of acting as a countervailing power, as potentially they could, most doctors have a 
shared interest in prescribing the industry’s products and not challenging it claims.”104  
 
5.3 Interes t ed Knowledge  and Medica l izat ion 
 
Making financial profit is evidently the aim of any private for profit company.  A lot of 
pressure comes along by trying to implement new products successfully on the market. Drug 
development is usually dependent on capital. In order to develop a drug in the first place, a 
pharmaceutical company needs an investor at the stock market. Rajan argues that a company 
starts with an idea, in his words, a vision and it needs investors in order to put the idea into 
practice. This means that the possibility to even start developing a drug is dependent on the 
company’s ability to convince potential investors to invest into their idea. Afterwards, the 
company is of course under high pressure to make profit: “The outcomes of innovative 
experiments are by definition unknowable; the market inputs into these experiments, on the 
other hand, need to calculate and look forward to a return on their investment.”105 
In order to get investors in the stock market, companies need to have a successful 
communication strategy. Rajan distinguishes between credibility and truth: “credibility rather than 
truth is essential to start with. At some fundamental level, it does not matter whether the 
promissory visions of a biotech company are true or not as long as they credible.”106 
Potential patients are the targets of the pharmaceutical industry. According to Rajan, 
everyone is now a “potential patient”, or in other words, as Rajan calls it, a “patient in waiting”: 
“…every person, no matter how healthy, is possibly someone who might fall ill, the potential 
market for a drug is enlarged from “diseased” people to, conceivably, everyone with purchasing 
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power.”107  
 
5.4 Medica l izat ion and Heal th Care 
 
Taking a pill became the easiest and quickest solution to a wide range of problems. As 
Busfield argues: “People increasingly see medicines as a way of solving a wide range of problems, 
which are transformed into illnesses, instead of seeing them as a possible solution for a narrower 
range of physical sicknesses.”108  
In western, capitalist societies, medicine is not only something that can heal an illness or 
disease, it has become a branch of the economy. However, it is not only medicine that has 
become a profitable business, there is a broad variety of health provisions one can choose from 
nowadays. As Nettleton argues: “Health maintenance involves the consumption of a range of 
goods and services which are increasingly marketed for their health-giving properties, such as 
food, exercise machines and fitness clubs.”109 However, it is important to point out once again, 
that “Health is something that lies within the control of the invidual”.110 In other words, the 
individual has become a consumer of a broad variety of health care measures. Especially private 
health care systems like the one in the United States provide a fertile ground for this. 
Furthermore, the profit-driven health care business fosters medicalization, and medicalization 
leads to more profit in return, as more and more people become patients with medicalization.  
Insurance companies are private companies with the aim of making a financial profit. 
Medicines are promoted to these insurance companies, and they draw their policies strictly on 
scientific, clinical research, measuring the success rate of all products, rather than paying for any 
kind of individual therapy for the patient. It is drawing only on that kind of evidence based 
medicine. As Filc argues: The approach adopts a business-like orientation to the practice of 
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medicine in terms of which the patient is regarded as analogous to an enterprise, who should 
consequently be ‘‘managed’’ by the health-careproviders or taught how to manage him- or 
herself.  
Health care is supposed to be a system that has to be planned and be manageable. 
According to Gottweis,  medicalization seems to have only been the first step to a total 
commodification of the body (translation of the author).111 Biomedicalization processes triggered 
by the pharmaceutical industry, operating on a globalizing, highly technological level, contribute 
to this commodificiation. 
 
5.5 Managed Care Systems 
 
 
Managed Care is a growing system of health care, coming from the United States. It is a 
good example of how health care and the market can be intertwined. The problem that most 
health care systems are facing is that all these new advancements in medicine are very costly. 
They have to cover the newest available treatments on the one hand, but on the other, private 
systems like in United States have to be profitable and thus cost-saving.112On the one hand, 
health care systems have to meet the newest scientific insights, but on the other hand, especially 
in so-called managed care systems, health care is embedded in the market-economy, which means 
it has to meet requirements of the market, be profitable, cost-saving etc.  
Furthermore, medical knowledge is influenced by the private industry, especially in 
Managed Care Systems, like in the United States. Rose argues that “The practice of medicine in 
most advanced industrialized countries has been colonized by, and reshaped by, the requirements 
of public or private insurance, their criteria for reimbursement, and in general their treatment of 
health and illness as merely another field for calculations of corporate profitability.”113 
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As demonstrated before, medicalization emerged out of the technocratic approach to 
health. The ability to measure and calculate health care is one of them. Health care is supposed to 
be a system that has to be planned and be manageable and therefore goes hand in hand with 
medicalization and biomedicalization. As modern biomedicine is making use of more and more 
expensive technologies, it is up to health care systems to regulate what can be covered by 
insurance and what not, as it is their responsibility to pay for it. Managed care systems, more than 
any other health care systems, draw their policies mainly on scientific, clinical, medical research 
rather than individual therapies and diagnosis. They have to have the ability to exactly measure 
their income and expenses in order to make profit. It has to be a system that has to be planned 
and be manageable. So what they draw on is clinical data in order to see how efficient available 
treatments are. Gottweis calls it “Verwissenschaftlichung der Medizin”114. Furthermore, he argues 
that managed care is a product of a “market-oriented medicine, which arose out of the 
dominance of a global, neoliberal meta-narrative” (translation of the author).115 In the case of 
pharmaceuticals it is the drug testing (clinical trials) that is most important for drug regulation 
policies. This means that one the one hand, medicine has to be highly scientific, but on the other 
hand, has to meet the demands of the market.  
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6. The Role of the Media in Shaping the Notion of Health 
 
 
Every individual is making its own choices nowadays in regards to treatment and 
prevention. Thus, the role of the media is important as the media provides all this information 
regarding health and medicine and eventually penetrates people with advertising campaigns. This 
means that in the long run, the media is also responsible for shaping our understanding of health. 
Because of the high competition, pharmaceutical companies spend a great deal of their budget in 
advertising and information campaigns. To illustrate how important marketing for the 
pharmaceutical industry is I want to refer to a study undertaken by Marc-André Gagnon und Joel 
Lexchin from the York-University in Toronto. It has proven that the United States 
pharmaceutical industry spends almost twice as much on marketing and incentives than on 
research and development. 116 Thus, one could argue that the pharmaceutical companies spend 
most of their budget to shape the public’s understanding of health, which gives them the chance 
to sell more of their products.  
     Companies use the media to make people “aware” of what kind of illness they might have. 
They are creating awareness by illustrating certain symptoms one could have, like tiredness or 
sluggishness, and claim to have found the perfect product in order to “treat” those symptoms. 
Now why are pharmaceutical industries so influential on our understanding of health? They are 
embedded in the free-market-economy and under a lot of pressure in order to sell their products. 
Thus, they are trying to target as many people as possible, not only sick people, but also people 
who are at risk. Everyone is constantly supposedly at risk nowadays. As Rajan argues: “… 
suggesting that every person, no matter how healthy, is possibly someone who might fall ill, the 
potential market for a drug is enlarged from “diseased” people to, conceivably, everyone with 
purchasing power, just as the domain of the therapeutic is enlarged progressively further back 
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toward prophylactic uses consequent to the moment of diagnosis.”117 This means that everyone is 
turned into a potential patient, in Rajan’s words, a patient-in-waiting. 
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6.1 Heal th ,  Media and the Market  
 
The demands of the free-market highly influence the demand for pharmaceuticals and the 
important role the media holds in advertising these products. The development is dual: On the 
one hand, the media penetrates the people with the promotion of new health care products and 
on the other hand, by these advertisements people become more aware of their health and well-
being and demand new products. As Bunton argues: “In the health sphere the growth in health- 
related goods and services is influenced by a market logic which produces both new products and 
new, more discerning, health-conscious consumers.”118 The health industry is constantly growing. 
Health could be claimed as the most valuable thing humans have in life, advertising and 
promotion is therefore very successful in the health spectrum and is growing constantly as a field 
of expertise: “On the one hand, there is an increased propensity found in magazines and 
periodicals to report on health matters and become involved in health education. On the other 
hand, there has arisen a field of expertise in health communications which has focused on the 
ability of campaigns and advertising to promote or diminish healthy behaviors and lifestyles.”119 
This means that health communication has become a new and profitable business. Health 
communications are so successful because health is no longer a given condition nowadays, it is 
something the individual has to work towards to and this is where the market comes into the 
field. The individual is the target of countless health-related advertising campaigns- appealing to 
everyone’s right to be empowered- and to choose between varieties preventative health care 
options. The most common slogan in direct-to-consumer advertising in the United States is 
probably: “Go ask your doctor if …. is right for you.” It means that we should go to the doctor 
suggesting the medicine we want to take. This can also again be linked to the notion of “the 
empowered patient”. Going to the doctor and asking him/her for a particular product might give 
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people the feeling that they are taking their health into their own hands, rather than having 
doctors simply telling them what to do.120 
This encouragement of people to go to the doctor and act empowered is also driven by 
the fact that the media started to highly criticize doctors and medical experts. As Bunton argues, 
referring to the magazine Good Housekeeping: “In contemporary articles, not only are doctors 
absent, but Good Housekeeping increasingly carries articles which are critical of medical 
authority, including titles such as: “Escape the tranquiliser trap”, “Borderline smear” (what to do 
in the light of medical advice), “Children in hospital”, “Are these the best GPs in Britain?””121 
 
6.2 Medica l  Experts  and the ir  Role  in the Media 
       
Being healthy or sick is something that people are supposed to feel for themselves. The 
role and meaning of health for society is obviously flexible and subject to change- depending on 
the political and economic circumstances. For instance, a long time ago, medicine was only 
supposed to treat abnormalities of the body to make it “normal” again. Furthermore, “The 
increased standardization of the therapeutic process was believed to promote scientific progress 
in medicine while protecting the public against inflated claims about the effects and uses of 
substances claimed as remedies to restore health.”122 
However, as soon as we consult a medical expert a distinction has to be made between 
the internal and external perception of health, as it might not be possible to explain or show 
someone else exactly how we feel. The internal perception is the patient's perception of her/his 
condition, whereas the external is the observation of the doctor. Patients have to simply trust 
doctors, which Foucault has highly criticized as it creates a regulation of power. From the 
                                                
120 This is my personal interpretation out of the fieldwork I did on researching various TV-advertisements for 
pharmaceuticals 
121 Bunton, 234 
122 Petyna, 10 
   - 56 - 
medicalization perspective, medical experts are very influential in a set of power relations that 
determines what the patient understands as illness. Furthermore, doctors are very often 
influenced themselves by the pharmaceutical industry.  
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7.  One example of Medicalization and the Media: The “Male Menopause” 
 
A very valuable example of how the pharmaceutical industry can change and influence 
the personal understanding of health through the media is  the so -called “male menopause”, the 
andropause. Andropause is supposedly caused by a decrease of the testosterone level coming 
with aging. Something that used to be seen as something normal that is happening to the male 
body in the course of life, was suddenly claimed to be a medical condition that needs treatment.  
The right advertising strategy convinced that a testosterone decrease is not just something 
normal happening to the body that comes with aging, it is now considered as a serious medical 
condition. As testosterone is responsible for “sex drive, musculature, aggressive behavior, hair 
growth, and other traits traditionally considered as masculine,”123 symptoms for low testosterone 
are supposedly a decrease of the libido, hair loss, a lack of energy and so on. With the invention 
of a treatment that can diminish this testosterone-decrease, andropause became a medical 
condition that supposedly requires treatment. The promotion of the male menopause opened up 
a great market for the pharmaceutical industry. Or maybe, in other words, the pharmaceutical 
industry opened up this market itself. As Conrad argues: “…the idea of a male menopause and 
the use of testosterone as a replacement therapy are reemerging, driven by technological advances 
made in the pharmaceutical realm and by the distribution of these drugs for an increasing range 
of male troubles. Both of these trends facilitate medicalization.”124 
In other words, the pharmaceutical industry promotes andropause by advertising the 
treatments and pointing out the purported symptoms. Testosterone is supposed to be 
responsible for all kinds of male attributes like musculature, aggressive behavior, hair growth and 
a high sex drive.125 Thus, the advertisement strategy can easily be very emotional and efficient, 
applied basically to men’s understanding of masculinity. Advertisements would for instance 
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convey messages directly or indirectly that men with a low testosterone level are less of a man. The 
potential target group includes basically all middle-aged men who feel a lack of energy or 
experience a decrease in hair growth. As Conrad argues: “Such promotion of testosterone for 
male menopause was profit driven… portraying testosterone as a magic pill that could work 
wonders for middle-aged patients”126.  
The promoted treatment for low testosterone is a gel that can be rubbed on the 
shoulders, called Androgel. On the website one finds the “Low T. Quiz” which is to “find out if 
you are at risk”.127 Looking at the questions they are asking at this quiz it demonstrates how every 
man could soon think that he suffers from andropause, as the questions are formulated for 
instance as following: “Are you sad/or grumpy”, “Do you have a lack of energy”, “Do you fall 
asleep after dinner”, “Do you have a decrease in strength or endurance?”128 If only three out of 
those three questions are marked with YES, the quiz suggests to consult a doctor for “Low T”.  
With these advertising campaigns, testosterone deficiency has been medicalized as an 
issue of everyday life. The symptoms listed are for instance “loss of energy, low sex drive, 
decreased sense of well-being, increased body fat”. Most people would probably feel addressed 
by these words, thinking of themselves as having low energy or are to fat. The language used on 
the website makes the solution sound quick and easy, by using androgel: “Using AndroGel every 
day can bring your T levels back to normal and keep them there. And once you get back the T 
you've been missing, you may experience lasting symptom relief.”129 Furthermore, there are 
potential risk factors pointed out on the website, for instance obesity, diabetes and high blood 
pressure. This goes back to my argument that according to the media in the free-market-
economy, everyone is constantly at risk.  
Androgel is a perfect example of how the pharmaceutical industry drives medicalization 
by turning more and more human conditions into medical conditions. The media makes people 
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aware of the fact that there is a medical condition such as andropause, and the solution for it is a 
medical one, called androgel.  
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Conclusion to the Research Question 
The most important goal of this thesis was to demonstrate that the pharmaceutical 
industry plays not only an important role in medical knowledge production and medicalization 
but is also a main driver of both. The short answer to my research question would be that the 
pharmaceutical industry is a main driver of medicalization and biomedical knowledge production 
because of neoliberalism. My argument is based on several reasons. First of all, the production of 
knowledge has changed with the impacts of neoliberal politics. However, knowledge should 
never be viewed as something that can actually uncover the truth. Kerkoff argues that “the actual 
knowledge researchers produce is not an accurate reflection of the world, but rather is a lens that 
offers a particular picture of the world at a particular point in time.”130 It is always important to 
look at the complexes of power behind the production of knowledge.  
Second of all, the pharmaceutical industry is one of the fastest growing branches of the 
global economy. Especially in the United States, health care became an important driver of the 
economy, promoting fitness, mental health, supplements and so on. Bunton argues that “This 
newer commodification is directed at lifestyle and social positioning whilst simultaneously 
providing the techniques of care of the self and subjectification. Health commodities act as 
carries of disciplinary power in this respect.”131 
Third of all, health care systems become increasingly privatized which means that they are 
aiming for financial profit and support the idea of a strictly standardized, measurable health care, 
which increases the market for pharmaceuticals and gives them a lot of room to promote pills 
and treatments. And finally, the process of biomedicalization, that has brought medicalization to 
the next level, penetrating more and more areas of peoples’ levels.  
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Another important aspect of this thesis was to demonstrate that privatization of health 
care has apparently changed the notion of health and the administration of bodies132 completely. 
American concepts of health care – privatization, liberalization, and transnationalization are 
spreading to Europe and throughout the world (translation of the author).133 This is all part of 
what Gottweis refers to as the neoliberal narrative. The narrative is not only reducing the power 
of the state, it is much more forcing the state to implement policies according to the laws of the 
market. Health, medicine and knowledge production are embedded within the neoliberal system.     
The free-market economy has obviously brought a lot of changes to the understanding of 
health as more and more products, treatments or other health related interventions have been 
developed and promoted through the media, which fosters medicalization. Health as a personal 
understanding as well as health care have been individualized, meaning that the individual is 
expected to take care of his/her own health to stay as healthy as possible, which includes to avoid 
risks, go to cancer screenings, eat healthy and to achieve a good “work-life-balance”.  
Because of the countless availability of actions for health prevention it seems that the 
individual can understand himself/herself as being constantly at risk.  The shift of responsibility 
for health to the individual has been interpreted widely as positive, claiming that it empowers 
people in regards to their health. This is one the main arguments in neoliberal philosophy, every 
individual is supposedly free making its own decisions on how to live its live. However, as Taylor 
argues, freedom cannot only be defined as the absence of external obstacles, as neoliberalism 
promotes it. The individual’s freedom is influenced by its internal perceptions of the society it is 
living in. “We can’t say that someone is free, on a self-realisation view, if he is totally unrealised, if 
for instance he is totally aware of his potential, if fulfilling it has never even arisen as a question 
for him, or I he is paralysed by the fear of breaking with some norm which he has internalised 
but which does not authentically reflect him.”134  Nevertheless, the message of being empowered 
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has been picked up for advertising strategies of pharmaceutical companies, trying to promote 
their products, encouraging the patient to consume medicine. Everyone is a potential costumer.  
In regards to treatment, taking a pill is very often the easiest and quickest solution to a 
health problem as opposed to changing a whole lifestyle. This contributes to the medicalization 
of society. As I have illustrated in my case study on andropause, people are willing to treat 
symptoms like low energy with a pill, instead of maybe questioning their own life style. According 
to Gottweis,  medicalization seems to have only been the first step to a total commodification of 
the body.135  
The advances in technology and medical research of the global pharmaceutical industry 
have further triggered a process called biomedicalization, which took medicalization to a higher 
level, reaching into even more areas of peoples’ lives and changing the personal notion of health 
once again. Bunton argues that “Medical Knowledge appears to have become marketed as one 
amongst many knowledge’s for consumption within the consumption of popular knowledge”136 
Biomedicalization brought medicalization and Foucault’s theories on biopolitics to the 
level of bioeconomics, as a part of the neoliberal system and with the most important aim of 
constant economic growth.  According to Rose, health seems to have just as much value as 
economic growth: “…as the OECD report remarks, bioeconomic circuits of exchange have as 
their organizing principle the capturing of the latent values in biological processes, a value that is 
simultaneously that of human health and that of economic growth.”137 
An important role in all this plays the media, as it is the tool for advertising all kinds of 
health treatments that make us aware of potential risks and symptoms we might have. Health-
Communications are by now very profitable businesses. The development is twofold: 
Medicalization drives Health-Promotions, and Health-Promotions drive medicalization. 
Furthermore, the pharmaceutical industry contributes to medicalization by producing all available 
treatments.  
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Especially in the United States, with a completely privatized health care system, health 
care became an important driver of the economy. Modern health care systems, like managed care 
systems have apparently changed the notion of health and the administration of bodies138 completely, 
and this might be only the beginning. These systems have to make financial profit and support 
the idea of strictly standardized, measurable health care, and thus reject a more individual, maybe 
social approach to health, which a is what probably a lot of people would need right now.  
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